David C. Pryde
WorldWide Medicinal Chemistry
Pfizer Global Research and Development
Sandwich
Kent, CT13 9NJ
England
Name/email consistency: high
- Aldehyde oxidase: an enzyme of emerging importance in drug discovery. Pryde, D.C., Dalvie, D., Hu, Q., Jones, P., Obach, R.S., Tran, T.D. J. Med. Chem. (2010)
- An in situ oxidation strategy towards overcoming hERG affinity. Pryde, D.C., Jones, R., Middleton, D.S., Laverty, B.J., Fenwick, D.R., Mason, H.J., Corless, M., Smith, N.N. Bioorg. Med. Chem. Lett. (2010)
- The design and discovery of novel amide CCR5 antagonists. Pryde, D.C., Corless, M., Fenwick, D.R., Mason, H.J., Stammen, B.C., Stephenson, P.T., Ellis, D., Bachelor, D., Gordon, D., Barber, C.G., Wood, A., Middleton, D.S., Blakemore, D.C., Parsons, G.C., Eastwood, R., Platts, M.Y., Statham, K., Paradowski, K.A., Burt, C., Klute, W. Bioorg. Med. Chem. Lett. (2009)
- Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Pryde, D.C., Cook, A.S., Burring, D.J., Jones, L.H., Foll, S., Platts, M.Y., Sanderson, V., Corless, M., Stobie, A., Middleton, D.S., Foster, L., Barker, L., Van Der Graaf, P., Stacey, P., Kohl, C., Coggon, S., Beaumont, K. Bioorg. Med. Chem. (2007)
- Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides. Pryde, D.C., Maw, G.N., Planken, S., Platts, M.Y., Sanderson, V., Corless, M., Stobie, A., Barber, C.G., Russell, R., Foster, L., Barker, L., Wayman, C., Van Der Graaf, P., Stacey, P., Morren, D., Kohl, C., Beaumont, K., Coggon, S., Tute, M. J. Med. Chem. (2006)